Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Lead HIV protease inhibitor from ArQule

Nov. 15, 1996

HIV protease inhibitors described by DuPont

Nov. 15, 1996

IL-2 treatment dramatically effective in AIDS patients

Nov. 8, 1996

Cel-Sci reports interim results from AIDS vaccine trial

Nov. 8, 1996

Spanish phase II trial to evaluate Remune in combination with antiviral agents

Nov. 8, 1996

Procept and MRC clinical collaboration on topical microbicide

Nov. 8, 1996

Novel nontoxic AIDS drug cleared for clinical trials

Nov. 8, 1996

Expanded access allowed for NTZ in AIDS patients

Nov. 8, 1996

Sankyo describes anti-HIV agents

Nov. 8, 1996

HIV protease-inhibitory tetronic acids from P&U

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...